首页 | 本学科首页   官方微博 | 高级检索  
检索        

高效快速降脂动物模型研究
引用本文:韩冰,寇淑鸣,陈彪,彭耀宗,王越,韩玉龙,叶小利,李学刚.高效快速降脂动物模型研究[J].中国中药杂志,2015,40(22):4446-4451.
作者姓名:韩冰  寇淑鸣  陈彪  彭耀宗  王越  韩玉龙  叶小利  李学刚
作者单位:西南大学生命科学学院, 重庆 400715,西南大学生命科学学院, 重庆 400715,西南大学生命科学学院, 重庆 400715,西南大学药学院, 重庆 400715,西南大学生命科学学院, 重庆 400715,西南大学生命科学学院, 重庆 400715,西南大学生命科学学院, 重庆 400715;重庆中药现代化生产力促进中心, 重庆 400715;重庆市药物过程与质量控制工程技术研究中心, 重庆 400715,西南大学药学院, 重庆 400715;重庆中药现代化生产力促进中心, 重庆 400715;重庆市药物过程与质量控制工程技术研究中心, 重庆 400715
基金项目:国家科技支撑计划项目(2011BAI13B02-1);高等学校博士学科点专项科研基金项目(20130182110023);重庆市百名高端工程技术人才计划项目(2013-2016)
摘    要:探讨斑马鱼作为降脂药物筛选模型的可行性以及盐酸小檗碱(BBR)对高脂斑马鱼的影响。用含4%胆固醇饲料喂养3月龄斑马鱼0,2,4,8,14,20,25,30 d,检测血清总胆固醇含量的变化;测定对照组、高胆固醇组、0.01%辛伐他汀组、0.1%BBR组和0.2%BBR组斑马鱼血清总胆固醇(TC)、总甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-c)和高密度脂蛋白胆固醇(HDL-c)的水平;RT-PCR检测肝脏HMGCR,LDLR和CYP7A1a mRNA的表达水平;油红O染色检测肝脏中脂肪含量的变化。结果显示4%胆固醇喂养斑马鱼后血清TC水平升高且有时间依赖性,20 d基本达到稳定水平;BBR组斑马鱼血清TC,TG和LDL-c水平显著下降,肝脏HMGCR mRNA的表达下降,LDLR和CYP7A1a mRNA的表达升高,脂肪含量减少。4%胆固醇饲料喂养斑马鱼20 d即可建立高脂斑马鱼模型,研究结果为进一步开展降脂药物的筛选奠定基础。

关 键 词:斑马鱼  高脂血症  盐酸小檗碱  HMGCR  LDLR  CYP7A1a
收稿时间:2015/3/29 0:00:00

Efficient and rapid liquid reduction animal model
HAN Bing,KOU Shu-ming,CHEN Biao,PENG Yao-zong,WANG Yue,HAN Yu-long,YE Xiao-li and LI Xue-gang.Efficient and rapid liquid reduction animal model[J].China Journal of Chinese Materia Medica,2015,40(22):4446-4451.
Authors:HAN Bing  KOU Shu-ming  CHEN Biao  PENG Yao-zong  WANG Yue  HAN Yu-long  YE Xiao-li and LI Xue-gang
Institution:School of Life Sciences, Southwest University, Chongqing 400715, China,School of Life Sciences, Southwest University, Chongqing 400715, China,School of Life Sciences, Southwest University, Chongqing 400715, China,School of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China,School of Life Sciences, Southwest University, Chongqing 400715, China,School of Life Sciences, Southwest University, Chongqing 400715, China,School of Life Sciences, Southwest University, Chongqing 400715, China;Chongqing Productivity Promotion Center for Modernization of Chinese Traditional Medicine, Chongqing 400715, China;Chongqing Engineer Technology Research Center for Pharmaceutical Process and Quality Control, Chongqing 400715, China and School of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China;Chongqing Productivity Promotion Center for Modernization of Chinese Traditional Medicine, Chongqing 400715, China;Chongqing Engineer Technology Research Center for Pharmaceutical Process and Quality Control, Chongqing 400715, China
Abstract:To investigate the practicability of establishing zebrafish lipid-lowering drug screening model and the effect of berberine (BBR) on hyperlipidemic zebrafish. Three-month-old zebrafishes were fed with 4% cholesterol for 0, 2, 4, 8, 14, 20, 25, 30 days, and the level of total cholesterol in serum was measured. Zebrafish were randomly divided into four groups:the control group, the high cholesterol diet group, the 0.01% simvastatin-treated group, the 0.1% berberine-treated group and the 0.2% berberine-treated group. The levels of total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-c) and high-density lipoprotein cholesterol (HDL-c) in serum were measured; the expression of hepatic HMGCR, LDLR and CYP7A1a mRNA expressions were detected by real time PCR. Oil red O staining was performed to observe the changes in fat content in the liver. According to the result, the level of serum TC in the 4% cholesterol diet group significantly was higher than that of the normal control group in a time-dependent manner and reached a stable level at the 20th day. The BBR group showed significant decreases in the levels of TC, TG and LDL-c, HMGCR mRNA expression and fat content and increases in LDLR and CYP7A1a mRNA. The hyperlipidemia zebrafish model was successfully established by feeding with 4% cholesterol for 20 days. The findings lay a foundation for further screenings on lipid-lowering drugs.
Keywords:zebrafish  hyperlipidemia  berberine  HMGCR  LDLR  CYP7A1a
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号